Possible mechanisms of elevation of serum transaminase levels during interferon-β therapy in chronic hepatitis C patients

Journal of Gastroenterology

Volumn 37, Issue 1, 2002, Pages 40-46

  Fujimori, Kenji ^a   Mochida, Satoshi ^a   Matsui, Atsushi ^a   Ohno, Akihiko ^a   Fujiwara, Kenji ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Chronic hepatitis; Hepatitis C virus; Hepatocyte apoptosis; Interferon ; Transaminase

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; BETA INTERFERON; IMMUNOGLOBULIN G; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; APOPTOSIS; ARTICLE; AUTOIMMUNE HEPATITIS; CELL INFILTRATION; CELL NUCLEUS; CELL VACUOLE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG CYTOTOXICITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MICROSCOPY; MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-BETA; LIVER; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 0036169983     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s535-002-8131-9     Document Type: Article

References (18)

1. Treatment of chronic hepatitis C with high-dose interferon α-2b. A multi-center study
2. Efficacy of long-term interferon treatment in chronic liver disease evaluated by sensitive polymerase chain assay for hepatitis C virus RNA
3. Efficacy of interferon α therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level
4. Loss of serum HCV-RNA at week 4 of interferon α therapy is associated with more favorable long-term response in patients with chronic hepatitis C
5. Effect of alcohol intake on the efficacy of interferon therapy in patients with chronic hepatitis C as evaluated by multivariate logistic regression analysis
6. Long-term biochemical and virological response to natural interferon α in patients with chronic hepatitis C
7. Recombinant interferon α-2a for treatment of chronic hepatitis C: Results of a multi-center randomized controlled dose study
8. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon β
9. Randomized control trial of interferon-β injections at 12-h intervals as a therapy for chronic hepatitis C
10. Classification of chronic hepatitis: Diagnosis, grading and staging
11. Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction
12. Typing of hepatitis C virus by polymerase chain reaction with two-specific primers: Application to clinical survey and tracing infectious sources
13. Clinical toxicity of the interferons
14. Current state of interferon therapy for chronic hepatitis C
15. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection
16. Immunological adverse effects of interferon treatment
17. Side effects of high-dose interferon therapy for chronic hepatitis C
18. Pharmacokinetics and clinical trials of HuIFN-β in malignant tumor